Ardelyx
Tracked across 5 events · 37 articles · First seen Apr 01, 2026 · Last active Sep 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Ardelyx appointed Rajani Dinavahi as its new Chief Medical Officer, which is expected to strengthen its pipeline and medical capabilities.
Apr 01, 2026 · 6 articles
Business
Impact: Ardelyx is the company hosting the earnings call to discuss its Q2 2026 financial results and business update.
Jul 23, 2026 · 6 articles
Regulatory
Impact: Ardelyx is the central company, facing a 17.86% stock drop, lowered guidance, and a securities investigation. Its credibility and future revenue outlook are negatively affected.
Aug 14, 2026 · 6 articles
Regulatory
Bronstein, Gewirtz & Grossman, LLC, LLC announced that a securities class action lawsuit has been filed against Ardelyx, Inc. (NASDAQ: ARDX) and certain of its officers. The lawsuit seeks to recover damages for alleged violations…
Impact: Ardelyx is the primary defendant in the securities class action, facing allegations of misleading statements about payer access barriers and overstated commercial prospects for XPHOZAH and IBSRELA. The lawsuit could lead to financial penalties, reputational damage, and increased scrutiny of its disclosures.
Sep 18, 2026 · 13 articles
Tech
Impact: Ardelyx is mentioned as Ali Rezaie, an author of the study, reports serving as a consultant for the company.
Apr 08, 2026 · 6 articles
80
Rosen Law Firm filed class action ArdelyxArdelyx Securities Class...
60
Bronstein, Gewirtz & Grossman, LLC filed class action ArdelyxArdelyx Securities Class...
60
Rosen Law Firm investigating allegations ArdelyxArdelyx Securities Class...
ERGEN INTELLIGENCE
Track Ardelyx live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard